Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cor Therapeutics Inc.

Division of Capricor Therapeutics Inc./Nile Therapeutics Inc.
www.mlnm.com

Latest From Dava Pharmaceuticals Inc.

Endo Targets Opana ER Abuse-Deterrent Filing In 2016

Endo International PLC continues to believe it can rebuild Opana ER, despite generic competition, by adding abuse-deterrent labeling and securing critical intellectual property protection.

Gynecology & Urology Infectious Diseases

Endo Targets Opana ER Abuse-Deterrent Filing In 2016

Endo continues to believe it can rebuild Opana ER, despite generic competition, by adding abuse-deterrent labeling and securing critical intellectual property protection.

BioPharmaceutical Business Strategies

Endo one-ups Valeant with $11.2bn bid for Salix

Endo International sent Salix Pharmaceuticals a $175 per share bid to acquire the gastrointestinal disease-focused pharma company that trumps the already accepted offer of $158 per share from Valeant Pharmaceuticals, which expects to complete its ongoing tender offer for outstanding Salix shares by 1 April.

Endo Makes A Play For Auxilium, But QLT Deal Gets In The Way

The Irish company made its interest for Auxilium public, but the takeover target is not ready to break its previous merger agreement with Canadian drugmaker QLT.

BioPharmaceutical Strategy
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register